Avalo Therapeutics, Inc

AmerisourceBergen is one of the nation's largest pharmaceutical services providers. The company provides branded pharmaceuticals, generic pharmaceuticals, biotech and specialty drugs, over-the-counter remedies and health and beauty aids to independent retail pharmacies, national and regional chains, hospitals, clinics, pharmacy benefit managers, prescription mail order facilities, physician offices and long-term care facilities. AmerisourceBergen operates in two segments: pharmaceutical distribution, which includes the operations of AmerisourceBergen Drug Corporation, Specialty Group and Packaging Group; and PharMerica, which includes the long-term care pharmacy and workers' compensation businesses. The company has more than 14,000 employees. AmerisourceBergen began operations in August of 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. It is one of the largest pharmaceuticals distributors in the United States and has its headquarters in Valley Forge, Pa., and a Western management center in Orange, Calif. R. David Yost has been the chief executive officer of AmerisourceBergen for more than nine years. He has been with the medical and health care company for over 32 years. Yost earned a BS degree from the United States Air Force Academy, and a MBA from the University of California-Los Angeles. AmerisourceBergen has 43 distribution centers providing daily delivery in the United States.

Hsiri Therapeutics is a pharmaceutical company based in Media, PA, dedicated to discovering and developing therapies for infections caused by drug-resistant bacteria and drug-resistant fungal diseases. Their research focuses on three main areas: mycobacterial infections, bacterial infections resistant to current treatments, and fungal infections resistant to drugs. With research concepts originating from Professor Marvin Miller at the University of Notre Dame, Hsiri Therapeutics has received support from the Department of Defense and the National Institutes of Health. Their discovery and research laboratories are located in South Bend, IN, with strong research collaborations in Bozeman, MT, and Singapore. Under the leadership of Chairman and CEO William Claypool, M.D., Hsiri Therapeutics aims to address the significant unmet medical need in the market by developing compounds targeting tuberculosis, non-tuberculous mycobacterial infections, drug-resistant bacterial infections, and drug-resistant fungal infections. With a team of experienced professionals, including Chief Scientific Officer Marvin Miller, Ph.D., Chief Financial Officer Ivan Joseph, MBA, and Chief Operating Officer Carrie Frey, MSC, MBA, Hsiri Therapeutics is committed to advancing antibiotic research and discovering new therapies for drug-resistant infections.Generated from the website

Janssen is one of the largest pharmaceutical companies in the United States. The company markets prescription medications for the treatment of schizophrenia, bipolar mania and autistic disorder. It offers products from the HALDOL, RISPERDAL and INVEGA brands. Janssen has been in business since 1953. The company deals in the development and research of compounds for a range of psychiatric disorders, including psychosis, sleep, anxiety, depression and substance abuse, and attention deficit and hyperactivity. Its facility is spread over an area of more than 270-acres. In addition, Janssen is a division of Ortho-McNeil-Janssen Pharmaceuticals. The company also provides patient assistance and medical education services.